Results 241 to 250 of about 6,427,330 (272)
Some of the next articles are maybe not open access.
Autotransplantation for Mantle Cell Lymphoma
The Cancer Journal, 2012Mantle cell lymphoma (MCL) represents about 5% to 9% of all non-Hodgkin lymphomas according to the World Health Organization. The clinical presentation typically consists of diffuse lymphadenopathy and frequent extranodal involvement of the gastrointestinal tract, blood, and bone marrow, as well as frequent splenomegaly.
openaire +2 more sources
Gastrointestinal Endoscopy, 2005
and the pelvis demonstrated no specific findings. At colonoscopy, the ileocecal valve showed an ulcerated growth extending to adjacent cecal wall. This growth showed multiple, irregular, marginated shallow ulcerations (A and B). The histopathology of the biopsied tissue from the ileocecal growth revealed a proliferation of large, atypical lymphoid ...
Michael T, Kram +2 more
openaire +2 more sources
and the pelvis demonstrated no specific findings. At colonoscopy, the ileocecal valve showed an ulcerated growth extending to adjacent cecal wall. This growth showed multiple, irregular, marginated shallow ulcerations (A and B). The histopathology of the biopsied tissue from the ileocecal growth revealed a proliferation of large, atypical lymphoid ...
Michael T, Kram +2 more
openaire +2 more sources
MicroRNAs in mantle cell lymphoma
Leukemia & Lymphoma, 2013Mantle cell lymphoma (MCL) is a rare and aggressive subtype of non-Hodgkin lymphoma. New treatment modalities, including intensive induction regimens with immunochemotherapy and autologous stem cell transplant, have improved survival. However, many patients still relapse, and there is a need for novel therapeutic strategies.
Husby, Simon +2 more
openaire +3 more sources
Therapy of mantle cell lymphoma
Orvosi Hetilap, 2009A köpenysejtes lymphoma egyesíti az indolens és az agresszív lymphomák rossz tulajdonságait, azaz az agresszív lymphomákhoz hasonlóan gyors lefolyású és progresszív, és az indolens lymphomákhoz hasonlóan kemoterápiával, illetve immunokemoterápiával nem gyógyítható.
openaire +2 more sources
Progression of CCND1− in situ mantle cell neoplasia to CCND1− mantle cell lymphoma
Blood, 2022Shaymaa E. Hegazy, Nathanael G. Bailey
openaire +2 more sources

